Cdk2 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Cdk2 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Overview
CDK2 (Cyclin-Dependent Kinase 2) is a serine/threonine kinase that plays central roles in cell cycle regulation, particularly at the G1/S and S phase transitions. CDK2 forms complexes with cyclin E and cyclin A to drive cells through S phase. While CDK2 is essential for cell proliferation, it also has important functions in post-mitotic neurons related to synaptic plasticity, DNA repair, and neuronal survival [@sherr1994][@van2000].
Protein Information
Structure
CDK2 has canonical CDK structure:
N-terminal kinase domain — Catalytic activity
C-terminal activation segment — Contains Thr160 phosphorylation site
Cyclin-binding interface — Binds cyclin E and cyclin A
Substrate recognition site — Recognizes RXL motif
CDK2 activation requires:
Cyclin binding (E or A)
Thr160 phosphorylation by CAK
Removal of inhibitory phosphorylation [@russo1996]
Normal Function
Cell Cycle Control
CDK2 regulates:
G1/S transition — With cyclin E, phosphorylates RB
S phase progression — With cyclin A, drives DNA replication
The study of Cdk2 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
External Links
[PubMed](https://pubmed.ncbi.nlm.nih.gov/) - Biomedical literature
[Alzheimer's Disease Neuroimaging Initiative](https://adni.loni.usc.edu/) - Research data
[Allen Brain Atlas](https://brain-map.org/) - Brain gene expression data